Immunogenicity of BNT162b2 Vaccine in Patients with Inflammatory Bowel Disease on Infliximab Combination Therapy: A Multicenter Prospective Study

Mohammad Shehab, Mohamed Abu-Farha, Fatema Alrashed, Ahmad Alfadhli, Khazna AlOtaibi, Abdulla AlSahli, Thangavel Alphonse Thanaraj, Arshad Channanath, Hamad Ali, Jehad Abubaker, Fahd Al-Mulla
doi: https://doi.org/10.1101/2021.10.20.21265239

Article usage

Article usage: October 2021 to December 2024

AbstractFullPdf
Oct 2021462877
Nov 2021225273
Dec 2021108239
Jan 202256810
Feb 20224206
Mar 20225035
Apr 20224107
May 202226111
Jun 202211028
Jul 20222401
Aug 20222834
Sep 20223536
Oct 20222819
Nov 20221013
Dec 20221005
Jan 20231618
Feb 2023841
Mar 20231734
Apr 20231623
May 20231136
Jun 2023941
Jul 2023641
Aug 202317123
Sep 20231153
Oct 20231000
Nov 20231262
Dec 2023912
Jan 20241002
Feb 20241121
Mar 2024716
Apr 202413139
May 2024522
Jun 2024502
Jul 2024914
Aug 20241496
Sep 20241853
Oct 2024461
Nov 2024702
Dec 2024414
Back to top
Posted October 20, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Immunogenicity of BNT162b2 Vaccine in Patients with Inflammatory Bowel Disease on Infliximab Combination Therapy: A Multicenter Prospective Study
Mohammad Shehab, Mohamed Abu-Farha, Fatema Alrashed, Ahmad Alfadhli, Khazna AlOtaibi, Abdulla AlSahli, Thangavel Alphonse Thanaraj, Arshad Channanath, Hamad Ali, Jehad Abubaker, Fahd Al-Mulla
medRxiv 2021.10.20.21265239; doi: https://doi.org/10.1101/2021.10.20.21265239
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area